tiprankstipranks
MediPharm Labs (MEDIF)
OTHER OTC:MEDIF

MediPharm Labs (MEDIF) Technical Analysis

404 Followers

Summary of all the Indicators

Overall Consensus
Sell
5Bullish
3Neutral
13Bearish
Technical Analysis Consensus
Buy
5Bullish
2Neutral
2Bearish
Moving Average Consensus
Strong Sell
0Bullish
1Neutral
11Bearish
MediPharm Labs’s (MEDIF) Moving Averages Convergence Divergence (MACD) indicator is >-0.01, suggesting MediPharm Labs is a Buy.
MediPharm Labs’s (MEDIF) 20-Day exponential moving average is 0.05, while MediPharm Labs’s (MEDIF) share price is <$0.1, making it a Sell.
MediPharm Labs’s (MEDIF) 50-Day exponential moving average is 0.05, while MediPharm Labs’s (MEDIF) share price is <$0.1, making it a Sell.

MediPharm Labs (MEDIF) Pivot Points

Jul 23, 2024, 10:50 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.05
0.05
0.05
0.05
0.05
0.05
0.05
Fibonacci
0.05
0.05
0.05
0.05
0.05
0.05
0.05
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

MediPharm Labs (MEDIF) Moving Averages

Jul 23, 2024, 10:50 AM
Period
Simple
Exponential
MA5
0.05Sell
0.05Sell
MA10
0.05Neutral
0.05Sell
MA20
0.05Sell
0.05Sell
MA50
0.06Sell
0.05Sell
MA100
0.06Sell
0.06Sell
MA200
0.05Sell
0.05Sell
MediPharm Labs’s (MEDIF) 10-Day exponential moving average is 0.05, while MediPharm Labs’s (MEDIF) share price is <$0.1, making it a Sell.
MediPharm Labs’s (MEDIF) 100-Day exponential moving average is 0.06, while MediPharm Labs’s (MEDIF) share price is <$0.1, making it a Sell.
MediPharm Labs’s (MEDIF) stock price is <$0.1 and MediPharm Labs’s (MEDIF) 50-day simple moving average is 0.06, creating a Sell signal.
MediPharm Labs’s (MEDIF) stock price is <$0.1 and MediPharm Labs’s (MEDIF) 100-day simple moving average is 0.06, creating a Sell signal.
MediPharm Labs’s (MEDIF) stock price is <$0.1 and MediPharm Labs’s (MEDIF) 200-day simple moving average is 0.05, creating a Sell signal.

MediPharm Labs (MEDIF) Technical Indicators

Jul 23, 2024, 10:50 AM
Name
Value
Implied Action
RSI (14)
42.80
Neutral
STOCH (9,6)
16.67
Buy
STOCHRSI (14)
14.81
Buy
MACD (12,26)
>-0.01
Buy
ADX (14)
13.35
Buy
Williams %R
-55.56
Buy
CCI (14)
-98.47
Neutral
ATR (14)
<0.01
-
Ultimate Oscillator
28.17
Sell
ROC
0.00
-
MediPharm Labs’s (MEDIF) Relative Strength Index (RSI) is 42.80, creating a Neutral signal.
MediPharm Labs’s (MEDIF) Trend Strength Indicator (ADX) is 13.35, creating a Buy signal.
MediPharm Labs’s (MEDIF) Commodity Channel Index (CCI) is -98.47, creating a Neutral signal.

FAQ

Is MEDIF a Buy, Hold, or Sell?
Based on MEDIF’s technical indicators, MEDIF is a Sell.
    What is MEDIF’s RSI (14)?
    MEDIF’s RSI (14) is 42.80, which suggests MEDIF is a Neutral.
      What is MEDIF’s MACD?
      MEDIF’s MACD is >-0.01, which suggests MEDIF is a Buy.
        What is MEDIF’s 5-day moving average?
        MEDIF’s 5-day moving average is 0.05, which suggests MEDIF is a Sell.
          What is MEDIF’s 20-day moving average?
          MEDIF 20-day moving average is 0.05, which suggests MEDIF is a Sell.
            What is MEDIF’s 50-day moving average?
            MEDIF’s 50-day moving average is 0.06, which suggests MEDIF is a Sell.
              What is MEDIF’s 200-day moving average?
              MEDIF’s 200-day moving average is 0.05, which suggests MEDIF is a Sell.
                What is MEDIF’s Williams % R (14)?
                MEDIF’s Williams % R (14) is -55.56, which suggests MEDIF is a Buy.
                  What is MEDIF’s CCI (14)?
                  MEDIF’s CCI (14) is -98.47, which suggests MEDIF is a Neutral.
                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis